Overexpression of LPA1 and LPA2 was readily observed in breast cancers with redundant mediation functions in multiple endogenous LPA responses, including cancer cell growth, metastasis, angiogenesis, and chemoresistance [8, 11–13]. The gene discussed is LPAR1; the disease is breast cancer.